← Association for Accessible Medicines
FDANonrulemakingFDA-2024-D-1461

Content and Format of Composition Statement and Corresponding Statement of Ingredients in Labeling in NDAs and ANDAs; Draft Guidance for Industry; Availability

RIN
—
Last modified
Jul 2, 2024
Comment window
closed 760d ago
Association for Accessible Medicines filings
1

Activity

Association for Accessible Medicines filed 1 comment on this docket between Jul 2, 2024 and Jul 2, 2024. 0 other organizations filed here. The comment window closed 760d ago.

What Association for Accessible Medicines filed (1)

Jul 2, 2024· Comment from Association for Accessible Medicines (AAM)· FDA-2024-D-1461-0004

AAM Comment letter

View on regulations.gov →

Abstract

No abstract recorded.

View on regulations.gov →

Co-filers (0)

See everyone who commented →